StockData
Stryker Corp logo

Stryker Corp (SYK) stock

SYKNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 30, 2026Score 18/306% below fair value
$317.54+6.82 (+2.19%)

Close on Nov 17, 2026Market cap $120.89BP/E 33.8Yield –

Stryker r&d expenses

Research and development expenses are spending on new products and technology.

Stryker's R&D Expenses for the twelve months ending Sep 30, 2026 was $1.68B, up 6.4% year over year. For fiscal 2025 it was $1.62B, up 10.7% from the year before. Over ten years it grew 10.0% a year on average. The highest annual figure on record is $1.62B in fiscal 2025.

Annual r&d expenses

PeriodPeriod endValueChange
FY2025Dec 31, 2025$1.62B+10.7%
FY2024Dec 31, 2024$1.47B+5.6%
FY2023Dec 31, 2023$1.39B-4.5%
FY2022Dec 31, 2022$1.45B+17.7%
FY2021Dec 31, 2021$1.24B+25.5%
FY2020Dec 31, 2020$984.00M+1.3%
FY2019Dec 31, 2019$971.00M+12.6%
FY2018Dec 31, 2018$862.00M+9.5%
FY2017Dec 31, 2017$787.00M+10.1%
FY2016Dec 31, 2016$715.00M+14.4%
FY2015Dec 31, 2015$625.00M+1.8%
FY2014Dec 31, 2014$614.00M+14.6%
FY2013Dec 31, 2013$536.00M+13.8%
FY2012Dec 31, 2012$471.00M+1.9%
FY2011Dec 31, 2011$462.00M+17.3%
FY2010Dec 31, 2010$394.00M+17.3%
FY2009Dec 31, 2009$336.00M-8.6%
FY2008Dec 31, 2008$367.80M-2.0%
FY2007Dec 31, 2007$375.30M–

Quarterly r&d expenses

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026$433.00M+5.6%
Q2 FY2026Jun 30, 2026$434.00M+6.6%
Q1 FY2026Mar 31, 2026$413.00M+2.0%
Q4 FY2025Dec 31, 2025$401.00M+12.0%
Q3 FY2025Sep 30, 2025$410.00M+8.8%
Q2 FY2025Jun 30, 2025$407.00M+12.1%
Q1 FY2025Mar 31, 2025$405.00M+10.1%
Q4 FY2024Dec 31, 2024$358.00M+2.3%
Q3 FY2024Sep 30, 2024$377.00M+6.8%
Q2 FY2024Jun 30, 2024$363.00M+4.9%
Q1 FY2024Mar 31, 2024$368.00M+8.6%
Q4 FY2023Dec 31, 2023$350.00M+7.4%
Q3 FY2023Sep 30, 2023$353.00M-3.0%
Q2 FY2023Jun 30, 2023$346.00M-1.4%
Q1 FY2023Mar 31, 2023$339.00M-17.9%
Q4 FY2022Dec 31, 2022$326.00M-1.5%
Q3 FY2022Sep 30, 2022$364.00M+19.0%
Q2 FY2022Jun 30, 2022$351.00M+13.2%
Q1 FY2022Mar 31, 2022$413.00M+43.4%
Q4 FY2021Dec 31, 2021$331.00M+29.8%
Q3 FY2021Sep 30, 2021$306.00M+26.4%
Q2 FY2021Jun 30, 2021$310.00M+33.0%
Q1 FY2021Mar 31, 2021$288.00M+13.4%
Q4 FY2020Dec 31, 2020$255.00M+0.4%
Q3 FY2020Sep 30, 2020$242.00M-1.6%
Q2 FY2020Jun 30, 2020$233.00M-5.3%
Q1 FY2020Mar 31, 2020$254.00M+12.9%
Q4 FY2019Dec 31, 2019$254.00M+14.9%
Q3 FY2019Sep 30, 2019$246.00M+11.3%
Q2 FY2019Jun 30, 2019$246.00M+13.9%
Q1 FY2019Mar 31, 2019$225.00M+10.3%
Q4 FY2018Dec 31, 2018$221.00M+7.8%
Q3 FY2018Sep 30, 2018$221.00M+11.6%
Q2 FY2018Jun 30, 2018$216.00M+12.5%
Q1 FY2018Mar 31, 2018$204.00M+6.3%
Q4 FY2017Dec 31, 2017$205.00M+8.5%
Q3 FY2017Sep 30, 2017$198.00M–
Q2 FY2017Jun 30, 2017$192.00M–
Q1 FY2017Mar 31, 2017$192.00M–
Q4 FY2016Dec 31, 2016$189.00M–

More Stryker figures

See a number that looks wrong?